View in EDS HTML Full Text PDF Full Text

Intra-subtype heterogeneity shapes treatment response in KMT2A-rearranged ALL across all age groups.

Saved in:
Bibliographic Details
Title: Intra-subtype heterogeneity shapes treatment response in KMT2A-rearranged ALL across all age groups.
Authors: Hartmann AM; Medical Department II, Hematology and Oncology University Medical Center Schleswig-Holstein, Campus Kiel Kiel Germany.; University Cancer Center Schleswig-Holstein (UCCSH) University Medical Center Schleswig-Holstein Kiel Germany.; Clinical Research Unit CATCH ALL KFO 5010 Kiel Germany., Bastian L; Medical Department II, Hematology and Oncology University Medical Center Schleswig-Holstein, Campus Kiel Kiel Germany.; University Cancer Center Schleswig-Holstein (UCCSH) University Medical Center Schleswig-Holstein Kiel Germany.; Clinical Research Unit CATCH ALL KFO 5010 Kiel Germany., Barz MJ; Medical Department II, Hematology and Oncology University Medical Center Schleswig-Holstein, Campus Kiel Kiel Germany.; University Cancer Center Schleswig-Holstein (UCCSH) University Medical Center Schleswig-Holstein Kiel Germany.; Clinical Research Unit CATCH ALL KFO 5010 Kiel Germany., Haas J; Division of Pediatric Oncology and Children's Research Center University Children's Hospital Zurich Zurich Switzerland., Amelunxen E; Medical Department II, Hematology and Oncology University Medical Center Schleswig-Holstein, Campus Kiel Kiel Germany., Ehm P; University Cancer Center Schleswig-Holstein (UCCSH) University Medical Center Schleswig-Holstein Kiel Germany.; Clinical Research Unit CATCH ALL KFO 5010 Kiel Germany.; Department of Pediatrics I, Pediatric Hematology/Oncology University Medical Center Schleswig-Holstein, Campus Kiel Kiel Germany., Lenk L; University Cancer Center Schleswig-Holstein (UCCSH) University Medical Center Schleswig-Holstein Kiel Germany.; Clinical Research Unit CATCH ALL KFO 5010 Kiel Germany.; Department of Pediatrics I, Pediatric Hematology/Oncology University Medical Center Schleswig-Holstein, Campus Kiel Kiel Germany., Kotrova M; Medical Department II, Hematology and Oncology University Medical Center Schleswig-Holstein, Campus Kiel Kiel Germany.; University Cancer Center Schleswig-Holstein (UCCSH) University Medical Center Schleswig-Holstein Kiel Germany., Beder T; Medical Department II, Hematology and Oncology University Medical Center Schleswig-Holstein, Campus Kiel Kiel Germany.; University Cancer Center Schleswig-Holstein (UCCSH) University Medical Center Schleswig-Holstein Kiel Germany., Steffen FD; Division of Pediatric Oncology and Children's Research Center University Children's Hospital Zurich Zurich Switzerland., Rauwolf K; Division of Pediatric Oncology and Children's Research Center University Children's Hospital Zurich Zurich Switzerland., Wolgast N; Medical Department II, Hematology and Oncology University Medical Center Schleswig-Holstein, Campus Kiel Kiel Germany.; University Cancer Center Schleswig-Holstein (UCCSH) University Medical Center Schleswig-Holstein Kiel Germany.; Clinical Research Unit CATCH ALL KFO 5010 Kiel Germany., Bendig S; Medical Department II, Hematology and Oncology University Medical Center Schleswig-Holstein, Campus Kiel Kiel Germany.; University Cancer Center Schleswig-Holstein (UCCSH) University Medical Center Schleswig-Holstein Kiel Germany.; Clinical Research Unit CATCH ALL KFO 5010 Kiel Germany., Bozzetti C; Medical Department II, Hematology and Oncology University Medical Center Schleswig-Holstein, Campus Kiel Kiel Germany.; University Cancer Center Schleswig-Holstein (UCCSH) University Medical Center Schleswig-Holstein Kiel Germany., Alten J; Department of Pediatrics I, Pediatric Hematology/Oncology University Medical Center Schleswig-Holstein, Campus Kiel Kiel Germany., Mondal M; Clinical Research Unit CATCH ALL KFO 5010 Kiel Germany.; Institute for Clinical Molecular Biology, University Medical Center Schleswig-Holstein, Campus Kiel Kiel Germany., Rademacher A; University Cancer Center Schleswig-Holstein (UCCSH) University Medical Center Schleswig-Holstein Kiel Germany.; Clinical Research Unit CATCH ALL KFO 5010 Kiel Germany.; Department of Pediatrics I, Pediatric Hematology/Oncology University Medical Center Schleswig-Holstein, Campus Kiel Kiel Germany., Heymann J; University Cancer Center Schleswig-Holstein (UCCSH) University Medical Center Schleswig-Holstein Kiel Germany.; Department of Pediatrics I, Pediatric Hematology/Oncology University Medical Center Schleswig-Holstein, Campus Kiel Kiel Germany., Walter W; MLL Munich Leukemia Laboratory Munich Germany., Haferlach C; MLL Munich Leukemia Laboratory Munich Germany., Ströh AS; Medical Department II, Hematology and Oncology University Medical Center Schleswig-Holstein, Campus Kiel Kiel Germany.; University Cancer Center Schleswig-Holstein (UCCSH) University Medical Center Schleswig-Holstein Kiel Germany., Bergmann AK; Clinical Genetics and Genomic Medicine University Hospital Würzburg Würzburg Germany., Burmeister T; Department of Hematology, Oncology and Cancer Immunology CVK, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin Berlin Germany., Gökbuget N; Department of Medicine II, Hematology/Oncology Goethe University Hospital Frankfurt am Main Germany., Bornhauser B; Division of Pediatric Oncology and Children's Research Center University Children's Hospital Zurich Zurich Switzerland., Bourquin JP; Division of Pediatric Oncology and Children's Research Center University Children's Hospital Zurich Zurich Switzerland., Brüggemann M; Medical Department II, Hematology and Oncology University Medical Center Schleswig-Holstein, Campus Kiel Kiel Germany.; University Cancer Center Schleswig-Holstein (UCCSH) University Medical Center Schleswig-Holstein Kiel Germany.; Clinical Research Unit CATCH ALL KFO 5010 Kiel Germany., Schrappe M; University Cancer Center Schleswig-Holstein (UCCSH) University Medical Center Schleswig-Holstein Kiel Germany.; Clinical Research Unit CATCH ALL KFO 5010 Kiel Germany.; Department of Pediatrics I, Pediatric Hematology/Oncology University Medical Center Schleswig-Holstein, Campus Kiel Kiel Germany., Cario G; University Cancer Center Schleswig-Holstein (UCCSH) University Medical Center Schleswig-Holstein Kiel Germany.; Clinical Research Unit CATCH ALL KFO 5010 Kiel Germany.; Department of Pediatrics I, Pediatric Hematology/Oncology University Medical Center Schleswig-Holstein, Campus Kiel Kiel Germany., Baldus CD; Medical Department II, Hematology and Oncology University Medical Center Schleswig-Holstein, Campus Kiel Kiel Germany.; University Cancer Center Schleswig-Holstein (UCCSH) University Medical Center Schleswig-Holstein Kiel Germany.; Clinical Research Unit CATCH ALL KFO 5010 Kiel Germany.
Source: HemaSphere [Hemasphere] 2026 Feb 19; Vol. 10 (2), pp. e70324. Date of Electronic Publication: 2026 Feb 19 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2572-9241
DOI:10.1002/hem3.70324